SOUDERS FINANCIAL ADVISORS Alnylam Pharmaceuticals, Inc. Transaction History

SOUDERS FINANCIAL ADVISORS portfolio value:

$334,000
portfolio value

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 1.66K shares 334K $200.16 1.66K